Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 541 to 550 of 550 entries
Sorted by: Best Match Show Resources per page
[No title available]

Plant phenomics (Washington, D.C.)

Janni M, Coppede N, Bettelli M, Briglia N, Petrozza A, Summerer S, Vurro F, Danzi D, Cellini F, Marmiroli N, Pignone D, Iannotta S, Zappettini A.
PMID: 33313533
Plant Phenomics. 2019 Nov 27;2019:6168209. doi: 10.34133/2019/6168209. eCollection 2019.

Drought stress imposes a major constraint over a crop yield and can be expected to grow in importance if the climate change predicted comes about. Improved methods are needed to facilitate crop management via the prompt detection of the...

Cite
Janni M, Coppede N, Bettelli M, et al. . Plant Phenomics. 2019;2019:6168209doi: 10.34133/2019/6168209.
Janni, M., Coppede, N., Bettelli, M., Briglia, N., Petrozza, A., Summerer, S., Vurro, F., Danzi, D., Cellini, F., Marmiroli, N., Pignone, D., Iannotta, S., & Zappettini, A. (2019). . Plant phenomics (Washington, D.C.), 20196168209. https://doi.org/10.34133/2019/6168209
Janni, Michela, et al. "." Plant phenomics (Washington, D.C.) vol. 2019 (2019): 6168209. doi: https://doi.org/10.34133/2019/6168209
Janni M, Coppede N, Bettelli M, Briglia N, Petrozza A, Summerer S, Vurro F, Danzi D, Cellini F, Marmiroli N, Pignone D, Iannotta S, Zappettini A. . Plant Phenomics. 2019 Nov 27;2019:6168209. doi: 10.34133/2019/6168209. eCollection 2019. PMID: 33313533; PMCID: PMC7706337.
Copy Download .nbib Format: NLM
Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study.

Blood

Rigolin GM, Del Giudice I, Bardi A, Melandri A, García-Jacobo RE, Cura F, Raponi S, Ilari C, Cafforio L, Piciocchi A, Arena V, Reda G, Albano F, Molica S, Sportoletti P, Trentin L, Marchetti M, Nanni M, Peragine N, Mariglia P, Vignetti M, Guarini A, Mauro FR, Foà R, Cuneo A.
PMID: 34587233
Blood. 2021 Dec 23;138(25):2727-2730. doi: 10.1182/blood.2021011883.

No abstract available.

Cite
Rigolin GM, Del Giudice I, Bardi A, et al. Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study. Blood. 2021;138(25):2727-2730doi: 10.1182/blood.2021011883.
Rigolin, G. M., Del Giudice, I., Bardi, A., Melandri, A., García-Jacobo, R. E., Cura, F., Raponi, S., Ilari, C., Cafforio, L., Piciocchi, A., Arena, V., Reda, G., Albano, F., Molica, S., Sportoletti, P., Trentin, L., Marchetti, M., Nanni, M., Peragine, N., Mariglia, P., Vignetti, M., Guarini, A., Mauro, F. R., Foà, R., & Cuneo, A. (2021). Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study. Blood, 138(25), 2727-2730. https://doi.org/10.1182/blood.2021011883
Rigolin, Gian Matteo, et al. "Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study." Blood vol. 138,25 (2021): 2727-2730. doi: https://doi.org/10.1182/blood.2021011883
Rigolin GM, Del Giudice I, Bardi A, Melandri A, García-Jacobo RE, Cura F, Raponi S, Ilari C, Cafforio L, Piciocchi A, Arena V, Reda G, Albano F, Molica S, Sportoletti P, Trentin L, Marchetti M, Nanni M, Peragine N, Mariglia P, Vignetti M, Guarini A, Mauro FR, Foà R, Cuneo A. Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study. Blood. 2021 Dec 23;138(25):2727-2730. doi: 10.1182/blood.2021011883. PMID: 34587233.
Copy Download .nbib Format: NLM
IL-15Rα-Independent IL-15 Signaling in Non-NK Cell-Derived IFNγ Driven Control of .

Frontiers in immunology

Nandi M, Moyo MM, Orkhis S, Mobulakani JMF, Limoges MA, Rexhepi F, Mayhue M, Cayarga AA, Marrero GC, Ilangumaran S, Menendez A, Ramanathan S.
PMID: 34956227
Front Immunol. 2021 Dec 10;12:793918. doi: 10.3389/fimmu.2021.793918. eCollection 2021.

Interleukin-15, produced by hematopoietic and parenchymal cells, maintains immune cell homeostasis and facilitates activation of lymphoid and myeloid cell subsets. IL-15 interacts with the ligand-binding receptor chain IL-15Rα during biosynthesis, and the IL-15:IL-15Rα complex is trans-presented to responder cells...

Cite
Nandi M, Moyo MM, Orkhis S, et al. IL-15Rα-Independent IL-15 Signaling in Non-NK Cell-Derived IFNγ Driven Control of . Front Immunol. 2021;12:793918doi: 10.3389/fimmu.2021.793918.
Nandi, M., Moyo, M. M., Orkhis, S., Mobulakani, J. M. F., Limoges, M. A., Rexhepi, F., Mayhue, M., Cayarga, A. A., Marrero, G. C., Ilangumaran, S., Menendez, A., & Ramanathan, S. (2021). IL-15Rα-Independent IL-15 Signaling in Non-NK Cell-Derived IFNγ Driven Control of . Frontiers in immunology, 12793918. https://doi.org/10.3389/fimmu.2021.793918
Nandi, Madhuparna, et al. "IL-15Rα-Independent IL-15 Signaling in Non-NK Cell-Derived IFNγ Driven Control of ." Frontiers in immunology vol. 12 (2021): 793918. doi: https://doi.org/10.3389/fimmu.2021.793918
Nandi M, Moyo MM, Orkhis S, Mobulakani JMF, Limoges MA, Rexhepi F, Mayhue M, Cayarga AA, Marrero GC, Ilangumaran S, Menendez A, Ramanathan S. IL-15Rα-Independent IL-15 Signaling in Non-NK Cell-Derived IFNγ Driven Control of . Front Immunol. 2021 Dec 10;12:793918. doi: 10.3389/fimmu.2021.793918. eCollection 2021. PMID: 34956227; PMCID: PMC8703170.
Copy Download .nbib Format: NLM
Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer.

Therapeutic advances in medical oncology

Rocca A, Cortesi P, Cortesi L, Gianni L, Matteucci F, Fantini L, Maestri A, Giunchi DC, Cavanna L, Ciani R, Falcini F, Bagni A, Meldoli E, Dall'Agata M, Volpi R, Andreis D, Nanni O, Curcio A, Lucchi L, Amadori D, Fedeli A.
PMID: 33613693
Ther Adv Med Oncol. 2021 Feb 09;13:1758835920985632. doi: 10.1177/1758835920985632. eCollection 2021.

BACKGROUND: The aim of this study was to improve activity over single human epidermal growth factor receptor 2 (HER2)-blockade sequential neaodjuvant regimens for HER2-positive breast cancer, by exploiting the concomitant administration of trastuzumab, taxane and anthracycline, while restraining cardiac...

Cite
Rocca A, Cortesi P, Cortesi L, et al. Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer. Ther Adv Med Oncol. 2021;13:1758835920985632doi: 10.1177/1758835920985632.
Rocca, A., Cortesi, P., Cortesi, L., Gianni, L., Matteucci, F., Fantini, L., Maestri, A., Giunchi, D. C., Cavanna, L., Ciani, R., Falcini, F., Bagni, A., Meldoli, E., Dall'Agata, M., Volpi, R., Andreis, D., Nanni, O., Curcio, A., Lucchi, L., Amadori, D., & Fedeli, A. (2021). Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer. Therapeutic advances in medical oncology, 131758835920985632. https://doi.org/10.1177/1758835920985632
Rocca, Andrea, et al. "Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer." Therapeutic advances in medical oncology vol. 13 (2021): 1758835920985632. doi: https://doi.org/10.1177/1758835920985632
Rocca A, Cortesi P, Cortesi L, Gianni L, Matteucci F, Fantini L, Maestri A, Giunchi DC, Cavanna L, Ciani R, Falcini F, Bagni A, Meldoli E, Dall'Agata M, Volpi R, Andreis D, Nanni O, Curcio A, Lucchi L, Amadori D, Fedeli A. Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer. Ther Adv Med Oncol. 2021 Feb 09;13:1758835920985632. doi: 10.1177/1758835920985632. eCollection 2021. PMID: 33613693; PMCID: PMC7876584.
Copy Download .nbib Format: NLM
Wine By-Products as Raw Materials for the Production of Biopolymers and of Natural Reinforcing Fillers: A Critical Review.

Polymers

Nanni A, Parisi M, Colonna M.
PMID: 33530517
Polymers (Basel). 2021 Jan 26;13(3). doi: 10.3390/polym13030381.

The plastic industry is today facing a green revolution; however, biopolymers, produced in low amounts, expensive, and food competitive do not represent an efficient solution. The use of wine waste as second-generation feedstock for the synthesis of polymer building...

Cite
Nanni A, Parisi M, Colonna M. Wine By-Products as Raw Materials for the Production of Biopolymers and of Natural Reinforcing Fillers: A Critical Review. Polymers (Basel). 2021;13(3)doi: 10.3390/polym13030381.
Nanni, A., Parisi, M., & Colonna, M. (2021). Wine By-Products as Raw Materials for the Production of Biopolymers and of Natural Reinforcing Fillers: A Critical Review. Polymers, 13(3), . https://doi.org/10.3390/polym13030381
Nanni, Alessandro, et al. "Wine By-Products as Raw Materials for the Production of Biopolymers and of Natural Reinforcing Fillers: A Critical Review." Polymers vol. 13,3 (2021). doi: https://doi.org/10.3390/polym13030381
Nanni A, Parisi M, Colonna M. Wine By-Products as Raw Materials for the Production of Biopolymers and of Natural Reinforcing Fillers: A Critical Review. Polymers (Basel). 2021 Jan 26;13(3). doi: 10.3390/polym13030381. PMID: 33530517; PMCID: PMC7865623.
Copy Download .nbib Format: NLM
The INCREASE project: Intelligent Collections of food-legume genetic resources for European agrofood systems.

The Plant journal : for cell and molecular biology

Bellucci E, Mario Aguilar O, Alseekh S, Bett K, Brezeanu C, Cook D, De la Rosa L, Delledonne M, Dostatny DF, Ferreira JJ, Geffroy V, Ghitarrini S, Kroc M, Kumar Agrawal S, Logozzo G, Marino M, Mary-Huard T, McClean P, Meglič V, Messer T, Muel F, Nanni L, Neumann K, Servalli F, Străjeru S, Varshney RK, Vasconcelos MW, Zaccardelli M, Zavarzin A, Bitocchi E, Frontoni E, Fernie AR, Gioia T, Graner A, Guasch L, Prochnow L, Oppermann M, Susek K, Tenaillon M, Papa R.
PMID: 34427014
Plant J. 2021 Nov;108(3):646-660. doi: 10.1111/tpj.15472. Epub 2021 Sep 23.

Food legumes are crucial for all agriculture-related societal challenges, including climate change mitigation, agrobiodiversity conservation, sustainable agriculture, food security and human health. The transition to plant-based diets, largely based on food legumes, could present major opportunities for adaptation and...

Cite
Bellucci E, Mario Aguilar O, Alseekh S, et al. The INCREASE project: Intelligent Collections of food-legume genetic resources for European agrofood systems. Plant J. 2021;108(3):646-660doi: 10.1111/tpj.15472.
Bellucci, E., Mario Aguilar, O., Alseekh, S., Bett, K., Brezeanu, C., Cook, D., De la Rosa, L., Delledonne, M., Dostatny, D. F., Ferreira, J. J., Geffroy, V., Ghitarrini, S., Kroc, M., Kumar Agrawal, S., Logozzo, G., Marino, M., Mary-Huard, T., McClean, P., Meglič, V., Messer, T., Muel, F., Nanni, L., Neumann, K., Servalli, F., Străjeru, S., Varshney, R. K., Vasconcelos, M. W., Zaccardelli, M., Zavarzin, A., Bitocchi, E., Frontoni, E., Fernie, A. R., Gioia, T., Graner, A., Guasch, L., Prochnow, L., Oppermann, M., Susek, K., Tenaillon, M., & Papa, R. (2021). The INCREASE project: Intelligent Collections of food-legume genetic resources for European agrofood systems. The Plant journal : for cell and molecular biology, 108(3), 646-660. https://doi.org/10.1111/tpj.15472
Bellucci, Elisa, et al. "The INCREASE project: Intelligent Collections of food-legume genetic resources for European agrofood systems." The Plant journal : for cell and molecular biology vol. 108,3 (2021): 646-660. doi: https://doi.org/10.1111/tpj.15472
Bellucci E, Mario Aguilar O, Alseekh S, Bett K, Brezeanu C, Cook D, De la Rosa L, Delledonne M, Dostatny DF, Ferreira JJ, Geffroy V, Ghitarrini S, Kroc M, Kumar Agrawal S, Logozzo G, Marino M, Mary-Huard T, McClean P, Meglič V, Messer T, Muel F, Nanni L, Neumann K, Servalli F, Străjeru S, Varshney RK, Vasconcelos MW, Zaccardelli M, Zavarzin A, Bitocchi E, Frontoni E, Fernie AR, Gioia T, Graner A, Guasch L, Prochnow L, Oppermann M, Susek K, Tenaillon M, Papa R. The INCREASE project: Intelligent Collections of food-legume genetic resources for European agrofood systems. Plant J. 2021 Nov;108(3):646-660. doi: 10.1111/tpj.15472. Epub 2021 Sep 23. PMID: 34427014.
Copy Download .nbib Format: NLM
[No title available]

The journal of physical chemistry. B

Shea JE, Crawford TD, Zanni M, Hartland G, Aumiller W.
PMID: 35021740
J Phys Chem B. 2022 Jan 13;126(1):1-2. doi: 10.1021/acs.jpcb.1c10543.

No abstract available.

Cite
Shea JE, Crawford TD, Zanni M, et al. . J Phys Chem B. 2022;126(1):1-2doi: 10.1021/acs.jpcb.1c10543.
Shea, J. E., Crawford, T. D., Zanni, M., Hartland, G., & Aumiller, W. (2022). . The journal of physical chemistry. B, 126(1), 1-2. https://doi.org/10.1021/acs.jpcb.1c10543
Shea, Joan-Emma, et al. "." The journal of physical chemistry. B vol. 126,1 (2022): 1-2. doi: https://doi.org/10.1021/acs.jpcb.1c10543
Shea JE, Crawford TD, Zanni M, Hartland G, Aumiller W. . J Phys Chem B. 2022 Jan 13;126(1):1-2. doi: 10.1021/acs.jpcb.1c10543. PMID: 35021740.
Copy Download .nbib Format: NLM
Special Issue "II-VI Semiconductor Nanocrystals and Hybrid Polymer-Nanocrystal Systems".

Nanomaterials (Basel, Switzerland)

Anni M.
PMID: 33673046
Nanomaterials (Basel). 2021 Feb 12;11(2). doi: 10.3390/nano11020467.

The continuous need to improve the performance of photonic, electronic and optoelectronic devices has stimulated research toward the development of innovative semiconducting materials which display better properties with respect to standard bulk semiconductors [...].

Cite
Anni M. Special Issue "II-VI Semiconductor Nanocrystals and Hybrid Polymer-Nanocrystal Systems". Nanomaterials (Basel). 2021;11(2)doi: 10.3390/nano11020467.
Anni, M. (2021). Special Issue "II-VI Semiconductor Nanocrystals and Hybrid Polymer-Nanocrystal Systems". Nanomaterials (Basel, Switzerland), 11(2), . https://doi.org/10.3390/nano11020467
Anni, Marco. "Special Issue "II-VI Semiconductor Nanocrystals and Hybrid Polymer-Nanocrystal Systems"." Nanomaterials (Basel, Switzerland) vol. 11,2 (2021). doi: https://doi.org/10.3390/nano11020467
Anni M. Special Issue "II-VI Semiconductor Nanocrystals and Hybrid Polymer-Nanocrystal Systems". Nanomaterials (Basel). 2021 Feb 12;11(2). doi: 10.3390/nano11020467. PMID: 33673046; PMCID: PMC7918414.
Copy Download .nbib Format: NLM
Mortality from cancer in people with severe mental disorders in Emilia Romagna Region, Italy.

Psycho-oncology

Grassi L, Stivanello E, Belvederi Murri M, Perlangeli V, Pandolfi P, Carnevali F, Caruso R, Saponaro A, Ferri M, Sanza M, Fioritti A, Meggiolaro E, Ruffilli F, Nanni MG, Ferrara M, Carozza P, Zerbinati L, Toffanin T, Menchetti M, Berardi D.
PMID: 34499790
Psychooncology. 2021 Dec;30(12):2039-2051. doi: 10.1002/pon.5805. Epub 2021 Sep 09.

OBJECTIVE: To examine cancer-related mortality in patients with severe mental disorders (SMI) in the Emilia Romagna (ER) Region, Northern Italy, during the period 2008-2017 and compare it with the regional population.METHODS: We used the ER Regional Mental Health Registry...

Cite
Grassi L, Stivanello E, Belvederi Murri M, et al. Mortality from cancer in people with severe mental disorders in Emilia Romagna Region, Italy. Psychooncology. 2021;30(12):2039-2051doi: 10.1002/pon.5805.
Grassi, L., Stivanello, E., Belvederi Murri, M., Perlangeli, V., Pandolfi, P., Carnevali, F., Caruso, R., Saponaro, A., Ferri, M., Sanza, M., Fioritti, A., Meggiolaro, E., Ruffilli, F., Nanni, M. G., Ferrara, M., Carozza, P., Zerbinati, L., Toffanin, T., Menchetti, M., & Berardi, D. (2021). Mortality from cancer in people with severe mental disorders in Emilia Romagna Region, Italy. Psycho-oncology, 30(12), 2039-2051. https://doi.org/10.1002/pon.5805
Grassi, Luigi, et al. "Mortality from cancer in people with severe mental disorders in Emilia Romagna Region, Italy." Psycho-oncology vol. 30,12 (2021): 2039-2051. doi: https://doi.org/10.1002/pon.5805
Grassi L, Stivanello E, Belvederi Murri M, Perlangeli V, Pandolfi P, Carnevali F, Caruso R, Saponaro A, Ferri M, Sanza M, Fioritti A, Meggiolaro E, Ruffilli F, Nanni MG, Ferrara M, Carozza P, Zerbinati L, Toffanin T, Menchetti M, Berardi D. Mortality from cancer in people with severe mental disorders in Emilia Romagna Region, Italy. Psychooncology. 2021 Dec;30(12):2039-2051. doi: 10.1002/pon.5805. Epub 2021 Sep 09. PMID: 34499790.
Copy Download .nbib Format: NLM
PET/CT-Guided Biopsy of Suspected Lung Lesions Requires Less Rebiopsy Than CT-Guided Biopsy Due to Inconclusive Results.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Cerci JJ, Bogoni M, Cerci RJ, Masukawa M, Neto CCP, Krauzer C, Fanti S, Sakamoto DG, Barreiros RB, Nanni C, Vitola JV.
PMID: 33384323
J Nucl Med. 2021 Aug 01;62(8):1057-1061. doi: 10.2967/jnumed.120.252403. Epub 2020 Dec 31.

The purpose of this study was to compare

Cite
Cerci JJ, Bogoni M, Cerci RJ, et al. PET/CT-Guided Biopsy of Suspected Lung Lesions Requires Less Rebiopsy Than CT-Guided Biopsy Due to Inconclusive Results. J Nucl Med. 2020;62(8):1057-1061doi: 10.2967/jnumed.120.252403.
Cerci, J. J., Bogoni, M., Cerci, R. J., Masukawa, M., Neto, C. C. P., Krauzer, C., Fanti, S., Sakamoto, D. G., Barreiros, R. B., Nanni, C., & Vitola, J. V. (2021). PET/CT-Guided Biopsy of Suspected Lung Lesions Requires Less Rebiopsy Than CT-Guided Biopsy Due to Inconclusive Results. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 62(8), 1057-1061. https://doi.org/10.2967/jnumed.120.252403
Cerci, Juliano J, et al. "PET/CT-Guided Biopsy of Suspected Lung Lesions Requires Less Rebiopsy Than CT-Guided Biopsy Due to Inconclusive Results." Journal of nuclear medicine : official publication, Society of Nuclear Medicine vol. 62,8 (2021): 1057-1061. doi: https://doi.org/10.2967/jnumed.120.252403
Cerci JJ, Bogoni M, Cerci RJ, Masukawa M, Neto CCP, Krauzer C, Fanti S, Sakamoto DG, Barreiros RB, Nanni C, Vitola JV. PET/CT-Guided Biopsy of Suspected Lung Lesions Requires Less Rebiopsy Than CT-Guided Biopsy Due to Inconclusive Results. J Nucl Med. 2021 Aug 01;62(8):1057-1061. doi: 10.2967/jnumed.120.252403. Epub 2020 Dec 31. PMID: 33384323.
Copy Download .nbib Format: NLM
Showing 541 to 550 of 550 entries